SERPINE1 and neoplasm: Elevated expression of PAI-1, therefore, may support tumor growth and cisplatin resistance in glioma cells through the PI3K/AKT pathway and, perhaps more importantly, it appears that PAI-1 is a druggable target, at least in glioblastoma.